Skip to header Skip to main navigation Skip to main content Skip to footer
Home
Academic Citations from Palestine
Foregrounding the Research of Academics in Palestine

Main navigation

  • Home
  • Search
  • About

Docking simulations and in vitro assay unveil potent inhibitory action of papaverine against protein tyrosine phosphatase 1B

Blank
Al-Azhar University – Gaza
Bustanji Y.; Taha M.O.; Al-masri I.M.; Mohammad K.
Bustanji, Yasser (8847282600); Taha, Mutasem Omar (7102056385); Al-masri, Ihab Mustafa (36573119700); Mohammad, Khalil (26531607500)
8847282600; 7102056385; 36573119700; 26531607500
2009
Biological and Pharmaceutical Bulletin
Docking simulations and in vitro assay unveil potent inhibitory action of papaverine against protein tyrosine phosphatase 1B
32
4
640
645
Faculty of Pharmacy, University of Jordan, Amman 11942, Jordan; Faculty of Pharmacy, Applied Science Private University, Amman, Jordan; Faculty of Pharmacy, Al-Azhar University, Gaza, Gaza Strip, Palestine
Bustanji Y., Faculty of Pharmacy, University of Jordan, Amman 11942, Jordan, Faculty of Pharmacy, Applied Science Private University, Amman, Jordan; Taha M.O., Faculty of Pharmacy, University of Jordan, Amman 11942, Jordan; Al-masri I.M., Faculty of Pharmacy, Applied Science Private University, Amman, Jordan, Faculty of Pharmacy, Al-Azhar University, Gaza, Gaza Strip, Palestine; Mohammad K., Faculty of Pharmacy, University of Jordan, Amman 11942, Jordan
Y. Bustanji; Faculty of Pharmacy, University of Jordan, Amman 11942, Jordan; email: bustanji@ju.edu.jo
21
10.1248/bpb.32.640
Diabetes mellitus; Docking simulation; Human protein tyrosine phosphatase 1B; Hypoglycemic activity; Papaverine; Tyrosine phosphatase
Animals; Blood Glucose; Computer Simulation; Dose-Response Relationship, Drug; Humans; Male; Mice; Mice, Inbred BALB C; Models, Molecular; Papaverine; Phosphodiesterase Inhibitors; Protein Tyrosine Phosphatase, Non-Receptor Type 1; Software; berberine; enzyme inhibitor; glucose; papaverine; protein tyrosine phosphatase 1B; recombinant enzyme; rk 682; unclassified drug; animal experiment; article; computer simulation; concentration response; controlled study; diet restriction; dose response; drug activity; drug conformation; drug dose comparison; drug dose escalation; drug effect; drug formulation; drug potency; drug protein binding; drug stability; drug structure; energy; enzyme inhibition; glucose blood level; hydrophobicity; hypoglycemic activity; IC 50; in vitro study; in vivo study; ionization; male; molecular docking; molecular interaction; mouse; nonhuman